Electrophysiological effects of anandamide on rat myocardium

British Journal of Pharmacology

Volumn 158, Issue 8, 2009, Pages 2022-2029

  Li, Qian ^a   Ma, Hui Jie ^a   Zhang, Hao ^a   Qi, Zhao ^a   Guan, Yue ^a   Zhang, Yi ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Action potential; Anandamide; Cardiomyocyte; Electrophysiology; L type Ca 2+ channel

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; CALCIUM CHANNEL; N(G) NITROARGININE METHYL ESTER; TETRYLAMMONIUM CHLORIDE;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DRUG EFFECT; EVOKED RESPONSE; HEART ELECTROPHYSIOLOGY; HEART MUSCLE; HEART PAPILLARY MUSCLE; HEART PROTECTION; MALE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; STEADY STATE; WHOLE CELL;

ACTION POTENTIALS; ANIMALS; ARACHIDONIC ACIDS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; ENDOCANNABINOIDS; HEART VENTRICLES; MALE; MYOCYTES, CARDIAC; PAPILLARY MUSCLES; PATCH-CLAMP TECHNIQUES; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 71649115398     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00518.x     Document Type: Article

References (29)

1. Alexander SPH, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edn. Br J Pharmacol 153 (Suppl. 2 S1 S209.
2. 1R's regulate cardiovascular function in hypertension. Circulation 110: 1996 2002.
3. 2+ current during long whole-cell recordings in guinea pig heart cells: role of phosphorylation and intracellular calcium. Pflugers Arch 411: 353 560.
4. Chang GJ, Su MJ, Hung LM, Lee SS (2002). Cardiac electrophysiologic and antiarrhythmic actions of a pavine alkaloid derivative, O-methylneocaryachine, in rat heart. Br J Pharmacol 136: 459 471.
5. 2+ channel and its role in myocyte electrophysiology: a theoretical investigation. Biophys J 92: 1522 1543.
6. Felder CC, Glass M (1998). Cannabinoid receptors and their endogenous agonists. Annu Rev Pharmacol Toxicol 38: 179 200.
7. Grant I, Cahn BR (2005). Cannabis and endocannabinoid modulators: therapeutic promises and challenges. Clin Neurosci Res 5: 185 199.
8. Hiley CR (2009). Endocannabinoids and the heart. J Cardiovasc Pharmacol 53: 267 276.
9. Hiley CR, Ford WR (2004). Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signaling. Biol Rev 79: 187 205.
10. Institute of Laboratory Animal Research, Commission on Life Sciences, National Research Council (1996). Guide for the Care and Use of Laboratory Animals. National Academy Press: Washington, DC.
11. Krylatov AV, Uzhachenko RV, Maslov LN, Bernatatskaya NA, Markriyannis A, Mekhoulam R et al. (2002a). Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: a possible mechanism. Bull Exp Biol Med 33: 122 124.
12. 2-receptors. Eksp Klin Farmakol 65: 6 9.
13. Lépicier P, Bouchard JF, Lagneux C, Lamontagne D (2003). Endocannabinoids protect the rat isolated heart against ischaemia. Br J Pharmacol 139: 805 815.
14. 1-receptors limit infarct size through NO formation in rat isolated hearts. Life Sci 81: 1373 1380.
15. Lopshire JC, Zipes DP (2006). Sudden cardiac death: better understanding of risks, mechanisms and treatment. Circulation 114: 1134 1136.
16. Matsuda LA, Lolait SJ, Brownstein MJ, Young AG, Bonner TI (1990). Structure of cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561 564.
17. Morad M, Tung L (1982). Ionic events responsible for the cardiac resting and action potential. Am J Cardiol 49: 584 594.
18. Munro S, Thomas KL, Abu-Shaar M (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature 65: 61 65.
19. Nattel S, Carlsson L (2006). Innovative approaches to anti-arrhythmic drug therapy. Nature reviews. Drug Discov 5: 1034 1049.
20. Pacher P, Hasko G (2008). Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 153: 252 256.
21. 2 receptors. Pharmacol Ther 74: 129 180.
22. Ralevic V, Kendall DA, Randall MD, Smart D (2002). Cannabinoid modulation of sensory neuron transmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function. Life Sci 71: 2577 2594.
23. Robert SK, Abriel H, Rivolta I (2001). Ion channels in the heart. In: Sperelakis N, Kurachi Y, Terzic A, Cohen MV (eds.). Heart Physiology and Pathophysiology, 4th edn. Academic Press: San Diego, CA, USA, pp. 1137 1151.
24. Splawski I, Timothy KW, Decher N, Kumar P, Sachse FB, Beggs AH et al. (2005). Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci USA 102: 8089 8096.
25. Triggle DJ (2007). Calcium channel antagonists: clinical uses-past, present and future. Biochem Pharmacol 74: 1 9.
26. 2 receptors. Bull Exp Biol Med 131: 251 253.
27. Underdown NJ, Hiley CR, Ford WR (2005). Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism. Br J Pharmacol 146: 809 816.
28. 1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts. J Cardiovasc Pharmacol 47: 650 655.
29. Wit AL, Janse MJ (2001). Reperfusion arrhythmia and sudden cardiac death: a century of progress toward an understanding of the mechanisms. Circ Res 89: 741 743.